Case Studies

Summit Peptides: Navigating Health Canada Compliance for Rapid Scale

Following the success in the Australian market, we applied our specialized compliance-to-growth framework to Summit Peptides, a Canadian research peptide brand facing severe platform restrictions and regulatory hurdles.

Summit Peptides

Following the success in the Australian market, we applied our specialized compliance-to-growth framework to Summit Peptides, a Canadian research peptide brand facing severe platform restrictions and regulatory hurdles.

Research Peptide

eCommerce

Meta Ads

Compliance

The Problem

Comprehensive Channel Suspension in a Highly Regulated Market

Summit Peptides arrived with a digital infrastructure that triggered multiple red flags under Health Canada’s strict guidelines and Meta/Google advertising policies.

Human-Use Language Violations:

The website and blog sections contained direct references to human consumption and therapeutic outcomes, violating research-only standards.

Compliance-Heavy Features:

The inclusion of a Peptide Calculator and a Peptide Guide Ebook created significant regulatory risk by implying dosage and application for human subjects.

Restricted Review Ecosystem:

The presence of a reviews section detailing user results led to immediate flagging for medicinal claims.

Multi-Platform Suspensions:

Accumulated violations resulted in full account suspensions across both Meta Ads and Google Ads, halting all paid acquisition.

Creative Rejections:

Ad imagery and copy were repeatedly rejected for violating health and medicinal product policies.

Outcomes

From suspended to scaling

When BodyLab came to us, their entire digital operation was stalled. Non-compliant content had triggered a cascade of platform penalties that made running ads — and growing the brand — nearly impossible.

removal of human-use language
0 %
Achieved full scalbility
0 %
ROAS improvement post-relaunch
0 X
Full restoration of Meta and Google Ads accounts
100 %

Ready to Scale Without Risk?

If you’re running a research peptide brand and struggling with ad disapprovals, scaling limitations, or compliance uncertainty — let’s fix it.